Basic Concepts of (Myocardial) Angiogenesis: Role of Vascular Endothelial Growth Factor and Angiopoietin

Carmeliet1

  • 1The Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, KU Leuven, Leuven, B-3000, Belgium.

Current Interventional Cardiology Reports
|November 30, 2000
PubMed

Insights

This review explores how the body forms new blood vessels (angiogenesis) and enlarges existing ones (arteriogenesis) to improve heart blood flow during ischemia. Understanding these processes, particularly the roles of vascular endothelial growth factor (VEGF) and angiopoietin (Ang), is key for developing new heart therapies.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Regenerative Medicine

Background:

  • Blood vessels supply oxygen and nutrients to the heart, crucial for function.
  • Ischemia, caused by blocked arteries, triggers compensatory blood vessel growth (angiogenesis and arteriogenesis).
  • Understanding molecular mechanisms of angiogenesis is vital for therapeutic strategies.

Purpose of the Study:

  • To review the roles of vascular endothelial growth factor (VEGF) and angiopoietin (Ang) in angiogenesis.
  • To discuss novel insights into hypoxia-driven regulation of angiogenesis.
  • To present a new mouse model for studying ischemic cardiomyopathy and therapeutic angiogenesis.

Main Methods:

  • Literature review of molecular mechanisms in angiogenesis and arteriogenesis.
  • Discussion of hypoxia's role in regulating blood vessel formation.
  • Presentation of a novel mouse model for ischemic cardiomyopathy.

Main Results:

  • VEGF and Ang are key classes of angiogenic molecules.
  • Hypoxia significantly regulates the process of angiogenesis.
  • A new mouse model exhibiting ischemic cardiomyopathy and hibernation provides a platform for research.

Conclusions:

  • Enhanced understanding of molecular pathways in angiogenesis is necessary for effective therapeutic design.
  • Targeting VEGF and Ang pathways, alongside hypoxia regulation, holds promise for improving myocardial perfusion.
  • The presented mouse model can advance research into therapeutic myocardial angiogenesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...